The global animal model market size accounted for US$ 2.48 billion in 2023 and is projected to reach around USD 5.72 billion by 2033, growing at a CAGR of 8.71% from 2024 to 2033.
Key Points
- North America led the market with the largest market share of 50% in 2023.
- By application type, the cancer segment has held the largest market share of 44% in 2023.
- By animal type, the mice & rat segment held the largest share of 53% in 2023.
- By end use, in 2023, the pharmaceutical & biotechnology companies segment has captured more than 40% of market share in 2023.
Report Summary
The global animal model market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the animal model market across the globe.
A comprehensive estimate on the animal model market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of animal model during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3890
Animal Model Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 8.71% |
| Global Market Size in 2023 | USD 2.48 Billion |
| Global Market Size by 2033 | USD 5.72 Billion |
| U.S. Market Size in 2023 | USD 0.93 Billion |
| U.S. Market Size by 2033 | USD 2.15 Billion |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Application, By Animal Type, and By End-use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized animal model market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Recombinant Antibodies Market Size to Cross USD 23.34 Bn by 2033
Market Players
The report includes the profiles of key animal model market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Recent Developments
- In September 2022, Solid Biosciences announced its acquisition of AavantiBio alongside a concurrent $75 million private placement.
- In April 2023, Merck bolstered its immunology pipeline with the acquisition of Prometheus Biosciences, Inc.
- In February 2023, AstraZeneca successfully completed the acquisition of CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company focused on developing novel treatments for resistant and uncontrolled hypertension as well as chronic kidney disease.
- In August 2023, Biocytogen established two business divisions to distinguish preclinical models and Services (BioMice) from antibody-drug R&D.
Animal Model Market Companies
- Charles River Laboratories
- The Jackson Laboratory
- genOway
- Taconic Biosciences, Inc.
- Janvier Labs
- Harbour BioMed
- Crown Bioscience
- Inotiv
- BIOCYTOGEN
- BioSpherix, Ltd.
Segments Covered in the Report
By Application
- Cancer
- Immunological Disease
- Infectious Disease
- Others
By Animal Type
- Mice
- Rat
- Guinea Pigs
- Rabbits
- Hamsters
- Others
By End-use
- Pharmaceutical & Biotechnology Companies
- Academic Research Institute
- Contract Research Organization
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Animal Model Market
5.1. COVID-19 Landscape: Animal Model Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Animal Model Market, By Application
8.1. Animal Model Market, by Application, 2024-2033
8.1.1 Cancer
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Immunological Disease
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Infectious Disease
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Animal Model Market, By Animal Type
9.1. Animal Model Market, by Animal Type, 2024-2033
9.1.1. Mice
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Rat
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Guinea Pigs
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Rabbits
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Hamsters
9.1.5.1. Market Revenue and Forecast (2021-2033)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Animal Model Market, By End-use
10.1. Animal Model Market, by End-use, 2024-2033
10.1.1. Pharmaceutical & Biotechnology Companies
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Academic Research Institute
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Contract Research Organization
10.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Animal Model Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Application (2021-2033)
11.1.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.1.3. Market Revenue and Forecast, by End-use (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Application (2021-2033)
11.1.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.1.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Application (2021-2033)
11.1.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.1.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Application (2021-2033)
11.2.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.2.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Application (2021-2033)
11.2.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.2.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Application (2021-2033)
11.2.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.2.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Application (2021-2033)
11.2.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.2.6.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Application (2021-2033)
11.2.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.2.7.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Application (2021-2033)
11.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.3.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Application (2021-2033)
11.3.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.3.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Application (2021-2033)
11.3.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.3.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Application (2021-2033)
11.3.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.3.6.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Application (2021-2033)
11.3.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.3.7.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Application (2021-2033)
11.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Application (2021-2033)
11.4.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.4.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Application (2021-2033)
11.4.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.4.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Application (2021-2033)
11.4.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.4.6.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Application (2021-2033)
11.4.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.4.7.3. Market Revenue and Forecast, by End-use (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Application (2021-2033)
11.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Application (2021-2033)
11.5.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.5.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Application (2021-2033)
11.5.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.5.5.3. Market Revenue and Forecast, by End-use (2021-2033)
Chapter 12. Company Profiles
12.1. Charles River Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. The Jackson Laboratory
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. genOway
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Taconic Biosciences, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Janvier Labs
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Harbour BioMed
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Crown Bioscience
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Inotiv
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. BIOCYTOGEN
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. BioSpherix, Ltd.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
